TITLE

Tax sops for pharma R&D may be extended

PUB. DATE
September 2006
SOURCE
Chemical Business;Sep2006, Vol. 20 Issue 9, p67
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports on the approval sought by the Ministry of Chemicals and Fertilizers of India from the Finance Ministry for the extension of the time limit of tax exemptions provided for research and development (R&D) activities in the pharmaceutical sector, in September 2006. Department of Chemicals and Petrochemicals secretary Satwant Reddy says that the tax exemption on R&D has been under consideration by the Ministry of Chemicals. The tax incentives will expire on March 31, 2007.
ACCESSION #
22733390

 

Related Articles

  • LPG subsidy not to be taxed: Finance Ministry.  // FRPT- Finance Snapshot;5/10/2015, p21 

    The article reports that the Finance Ministry of India clarified that LPG subsidy received by individuals in their bank accounts continues to be exempt from income tax, stating that this clarification originated from doubts of tax experts over a Finance Bill 2015 amendment expanding taxable income.

  • Tax exemptions may be withdrawn. Aiyar, Sharda // Chemical Business;Jan1996, Vol. 9 Issue 6, p57 

    Reports on Indian Finance Ministry's attempt to introduce three or four rates of tax which would be acceptable and add buoyancy to revenue collection. Problems with the present tax structure; Call for the elimination of tax exemptions; Emergence of zero-tax companies as a result of tax exemptions.

  • DIRECT TAXES CODE 2013: AN OVERVIEW. GUPTA, ALOKE // CLEAR International Journal of Research in Commerce & Managemen;Aug2014, Vol. 5 Issue 8, p73 

    After releasing Direct Tax Code on August 12, 2009 (DTC-I) and revised Direct Taxes Code on August 30, 2010 (DTC-II), again a fresh bill in the form of Direct Tax Code 2013 (DTC-III) was tabled on April 1, 2014 by the Indian Ministry of Finance (MoF) for public comments and review, with the aim...

  • Excise exemption for in-house consumed yarns, fabrics.  // Colourage;Feb2004, Vol. 51 Issue 2, p97 

    This article focuses on the move by the Finance Ministry of India to exempt yarns and unprocessed fabrics used for 'home consumption' from payment of excise duty. The move is expected to benefit large mills as well as small textile processors in centers such as Tirupur, Ludhiana, and Panipat. In...

  • Washington letter.  // DCI;Feb94, Vol. 154 Issue 2, p10 

    Focuses on the Congress' failure to do away with at least part of the Section 936 exception from taxes of drug manufacturers operating in Puerto Rico. Details of a December 21, 1994 article from `The Wall Street Journal.'

  • INDIAN SCENE.  // Chemical Business;Feb2000, Vol. 14 Issue 2, p72 

    Presents news briefs related to chemical and pharmaceutical industries in India as of February 2000. Plans of the Union Chemicals and Fertilizers Ministry to set up an internal export promotion cell to increase exports of chemicals and pharmaceuticals; Approval of the acquisition of the running...

  • IDMA calls for progressive drug pricing policy.  // Chemical Business;Oct2005, Vol. 19 Issue 10, p84 

    Provides information on a letter written by the Indian Drug Manufacturer's Association to the Indian Union Chemicals and Fertilisers Ministry urging a policy of price decontrol with competition in India. Possible impact of price control on the pharmaceutical industry; Advantages of price decontrol.

  • Finance Ministry not in favour of wealth fund for overseas fertiliser acquisitions; suggests alternative.  // FRPT- Chemical Snapshot;3/ 9/2014, p9 

    The article reports that Indian's Ministry of Finance (MoF) has not confirmed its support for the establishment of a Sovereign Wealth Fund (SWF) proposed by the Department of Fertilizers (DoF). It notes that while the SWF aims to support Indian companies in the acquisition of fertilizer plants...

  • Budget to spur R&D invesments by pharma cos.  // Chemical Business;Apr2012, Vol. 26 Issue 4, p42 

    The article reports on the expectation that the extension of a tax exemption for research and development (R&D) in India will encourage pharmaceutical companies to invest more in R&D.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics